Relay Medical’s (OTC: RYMDF) Glow LifeTech Investment Files Natural Health Product with Health Canada, Following Successful COVID-19 Phase II Clinical Trial and North American Exclusive Rights

Toronto, Ontario– April 27, 2021 – Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) (“Relay” or the “Company“), a shareholder of Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) (“Glow“), is pleased to provide an update on recently disseminated news by Glow LifeTech Corp.

On April 27, 2021, Glow reported on submitting an application to Health Canada to obtain produce licenses for its Natural Health Product (NHP), ArtemiC™, which reported successful results from a COVID-19 Phase II clinical trial.1

Glow is a biotech company focused on producing next-generation, science-backed natural products. ArtemiC™ was submitted to Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) on Mar 11, 2021. The application, which is currently under review by Health Canada, included ArtemiC™, which Glow receive exclusive rights to in early February.2

“Canada has the potential to set the world stage for COVID-19 Natural Health Products. With Health Canada approval and favorable clinical results, ArtemiC™ could become an evidence backed all-natural solution to aid patient recovery,” stated Yoav Raiter, CEO, Relay Medical Corp. “Glow has exclusive rights to market, sell, and distribute ArtemiC™ in Canada, the United States, Mexico, and all Caribbean countries as a food supplement (nutraceutical, dietary supplement, and natural health product).”

For the full and complete update from Glow, please refer to their news release3

The Company is not making any express or implied claims that it has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

About Glow LifeTech Corp.
Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with enhanced bioavailability, absorption, and effectiveness. Glow has rights to the groundbreaking, plant-based MyCell Technology® delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of valuable ingredients.


About Relay Medical Corp.

Relay Medical is a technology innovator headquartered in Toronto, Ontario with a team of experts focused on the development of novel technologies in the diagnostics and AI data science and IoT security sectors.

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.